Notch Therapeutics
- Employees
- 11–50
- Business Model
- B2B
- Website
- notchtx.com
- Total Funding
- $112.0M
- Last Round
- $21.0M Series BJan 2024
- Rounds
- 3
About
Early-stage biotech developing off-the-shelf CAR-T cell therapies via a proprietary T cell-production platform.
Summary
Notch Therapeutics is a Biotech company. It has raised $112.0M in total across 3 rounds, most recently a $21.0M Series B round in Jan 2024. Investors include CCRM, EcoR1 Capital and Amplitude Ventures.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.